Cancer clinical trials in the region Pays de la Loire
174 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Pancreas cancer
#NCT05706129
Adenocarcinoma
Locally Advanced
Metastatic
Chemotherapy
Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Universitaire de Nantes (Nantes), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 2
Pancreas cancer
#NCT04976634
Adenocarcinoma
Locally Advanced
Metastatic
Chemotherapy
Immunotherapy
Targeted therapy
Systemic Treatment-Naive
Immunotherapy
Targeted therapy
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut du cancer de Montpellier (Montpellier), Centre Hospitalier Universitaire de Grenoble (La Tronche), Institut Sainte Catherine (Avignon), Centre Eugene Marquis (Rennes) (and 1 more...)
Merck KGaA
Phase 2
Lung cancer
#NCT05882734
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
EGFR
ALK
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier) (and 2 more...)
Merck KGaA
Phase 2
Lung cancer
#NCT03915678
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Immunotherapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Oscar Lambret (Lille) (and 4 more...)
Institut Bergonié
Phase 2
Colon cancer
Rectal cancer
#NCT04420884
Adenocarcinoma
Locally Advanced
Metastatic
MSI/dMMR
MSS
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Léon Bérard (Lyon), Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), Centre François Baclesse (Caen ), Hôpital de la Timone AP-HM (Marseille) (and 7 more...)
Takeda
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Mantel cell lymphoma
CD20
None
1
2
3 or more
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Follicular lymphoma
CD20
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie
Phase 2
Lung cancer
#NCT05967689
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), CHU Caen Normandie (Caen), Institut Curie - Paris (Paris), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Universitaire Laennec (Saint-Herblain) (and 4 more...)
Taiho Oncology
Phase 2
Lymphoma
#NCT05963074
B cell lymphoma
Lymphocytic lymphoma
Systemic Treatment-Naive
None
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Hôpital Pitié Salpêtrière - AP-HP (Paris), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 1 more...)
Janssen
Phase 2
Breast cancer
#NCT05955170
HER2 Positive
Metastatic
Chemotherapy
Targeted therapy
Chemotherapy
Targeted therapy
Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud), Institut Sainte Catherine (Avignon), Hôpital Privé du Confluent - Vivalto Santé (Nantes)
Institut Curie